ECOR

electroCore, Inc.

Add to Watchlist

Advanced Chart

5.620

+0.54(10.630%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

5.650

Open

5.050

VWAP

5.40

Vol

120.30K

Mkt Cap

42.62M

Low

5.050

Amount

649.80K

EV/EBITDA(TTM)

Total Shares

6.44M

31.38M

EV/OCF(TTM)

P/S(TTM)

1.51

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

7.84M

+19.69%

8.84M

+25.46%

9.49M

+41.28%

Estimates Revision

The market is revising Upward the revenue expectations for electroCore, Inc. (ECOR) for FY2025, with the revenue forecasts being adjusted by 0.77% over the past three months. During the same period, the stock price has changed by 13.08%.

Revenue Estimates for FY2025

Revise Upward

+0.77%

In Past 3 Month

Stock Price

Go Up

+13.08%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast ECOR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ECOR is 18.50 USD with a low forecast of 12.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 5.620

Low

12.00

Averages

18.50

High

25.00

Current: 5.620

Low

12.00

Averages

18.50

High

25.00

Ladenburg Thalmann

Jeffrey Cohen

Strong Buy

Maintains

$28 → $26

2025-03-13

Reason

Ladenburg Thalmann

Jeffrey Cohen

Price Target

$28 → $26

2025-03-13

Maintains

Strong Buy

Reason

Ladenburg lowered the firm's price target on electroCore to $26 from $28 and keeps a Buy rating on the shares. The firm is "encouraged" by the company's performance in 2024 and sees continued growth potential, says the analyst, whose revised price target reflects the adjusted timing of revenues, but "still demonstrates significant growth in key channels."

HC Wainwright & Co.

Swayampakula Ramakanth

Strong Buy

Reiterates

$25

2025-03-13

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Price Target

$25

2025-03-13

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Strong Buy

Maintains

$22 → $25

2024-12-18

Reason

HC Wainwright & Co.

Swayampakula Ramakanth

Price Target

$22 → $25

2024-12-18

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for electroCore, Inc. (ECOR.O) is -4.81, compared to its 5-year average forward P/E of -4.74. For a more detailed relative valuation and DCF analysis to assess electroCore, Inc. 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-4.74

Current PE

-4.81

Overvalued PE

-0.57

Undervalued PE

-8.92

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-2.57

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

1.73

Undervalued EV/EBITDA

-6.88

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

5.01

Current PS

0.00

Overvalued PS

10.22

Undervalued PS

-0.20

Financials

Annual

Quarterly

FY2025Q2

YoY :

+20.23%

7.38M

Total Revenue

FY2025Q2

YoY :

+35.31%

-3.51M

Operating Profit

FY2025Q2

YoY :

+38.27%

-3.67M

Net Income after Tax

FY2025Q2

YoY :

+15.79%

-0.44

EPS - Diluted

FY2025Q2

YoY :

-63.43%

-648.00K

Free Cash Flow

FY2025Q2

YoY :

+1.08%

87.28

Gross Profit Margin - %

FY2025Q2

YoY :

-40.80%

-27.65

FCF Margin - %

FY2025Q2

YoY :

+15.01%

-49.74

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

71.3K

USD

Months

3-6

113.9K

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 168.84% over the last quarter.

Sold

0-3

Months

428.0K

Volume

3-6

Months

159.2K

Volume

6-9

Months

756.3K

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

956.5K

Volume

Months

6-9

198.8K

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

71.3K

USD

Months

3-6

113.9K

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

ECOR News & Events

Events Timeline

2025-08-12 (ET)

2025-08-12

08:19:33

electroCore appoints Benning as SVP of Truvaga

2025-08-05 (ET)

2025-08-05

08:27:46

electroCore appoints James Theofilos to board of directors

2025-05-02 (ET)

2025-05-02

08:02:57

electroCore completes acquisition of NeuroMetrix

News

9.5

05-09Yahoo Finance

electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ...

1.0

05-09Globenewswire

Metals and Mining Virtual Investor Conference: Presentations Now Available for Online Viewing

8.5

05-02Newsfilter

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies